Magnus Vrethem

4.2k total citations · 1 hit paper
108 papers, 3.0k citations indexed

About

Magnus Vrethem is a scholar working on Neurology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Magnus Vrethem has authored 108 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Neurology, 41 papers in Pathology and Forensic Medicine and 23 papers in Immunology. Recurrent topics in Magnus Vrethem's work include Multiple Sclerosis Research Studies (40 papers), Peripheral Neuropathies and Disorders (34 papers) and Systemic Lupus Erythematosus Research (12 papers). Magnus Vrethem is often cited by papers focused on Multiple Sclerosis Research Studies (40 papers), Peripheral Neuropathies and Disorders (34 papers) and Systemic Lupus Erythematosus Research (12 papers). Magnus Vrethem collaborates with scholars based in Sweden, United States and United Kingdom. Magnus Vrethem's co-authors include Jan Ernerudh, Charlotte Dahle, Martin Gunnarsson, Jan Lycke, Anders Svenningsson, Tomas Olsson, Fredrik Piehl, Jan Hillert, Pia Forsberg and C. Ekerfelt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Magnus Vrethem

107 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

2019 346 citations Jan Hillert, Jan Lycke et al. profile →

Peers

Countries citing papers authored by Magnus Vrethem

Since Specialization

Citations

This map shows the geographic impact of Magnus Vrethem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Vrethem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Vrethem more than expected).

Fields of papers citing papers by Magnus Vrethem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Vrethem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Vrethem. The network helps show where Magnus Vrethem may publish in the future.

Co-authorship network of co-authors of Magnus Vrethem

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Vrethem. A scholar is included among the top collaborators of Magnus Vrethem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Vrethem. Magnus Vrethem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	OCT and VEP correlate to disability in secondary progressive multiple sclerosis 2022 ·Multiple Sclerosis and Related Disorders ·(unknown), Yu-Min Huang, (unknown), Charlotte Dahle, Magnus Vrethem, (unknown)	6
2	Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis 2020 ·Journal of Neuroimmunology ·Irene Håkansson, Jan Ernerudh, Magnus Vrethem, Charlotte Dahle, Kristina Nilsson Ekdahl	11
3	Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS 2019 ·Multiple Sclerosis and Related Disorders ·Irene Håkansson, Lovisa Johansson, Charlotte Dahle, Magnus Vrethem, Jan Ernerudh	23
4	Oxylipins in cerebrospinal fluid in clinically isolated syndrome and relapsing remitting multiple sclerosis 2018 ·Prostaglandins & Other Lipid Mediators ·(unknown), Sandra Gouveia‐Figueira, Jan Ernerudh, Magnus Vrethem, Nazdar Ghafouri, Bijar Ghafouri, Malin L. Nording	11
5	Increased prevalence of celiac disease in idiopathic inflammatory myopathies 2017 ·Brain and Behavior ·Olof Danielsson, Björn Lindvall, Claes Hallert, Magnus Vrethem, Charlotte Dahle	11
6	Regulatory T cells in Multiple Sclerosis – Indications of impaired function of suppressive capacity and a role for chemokines 2014 ·Health Policy and Planning ·(unknown), Charlotte Dahle, Magnus Vrethem, Mika Gustafsson, Mikael Benson, Maria C. Jenmalm, Jan Ernerudh	1
7	Occurrence of epileptiform discharges and sleep during EEG recordings in children after melatonin intake versus sleep-deprivation 2014 ·Clinical Neurophysiology ·(unknown), Anders Broström, Martin Ulander, Magnus Vrethem, Eva Svanborg	25
8	Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia 2013 ·Psychiatry Research ·Martin Samuelsson, Elisabeth Skogh, Kristina Lundberg, Magnus Vrethem, Karin Öllinger	24
9	Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients 2013 ·PLoS ONE ·Johan Mellergård, (unknown), Maria C. Jenmalm, Charlotte Dahle, Magnus Vrethem, Jan Ernerudh	36
10	Taurine and glutathione levels in plasma before and after ECT treatment 2012 ·Psychiatry Research ·Martin Samuelsson, (unknown), Karin Öllinger, Magnus Vrethem	9
11	Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against Borrelia antigen in the cerebrospinal fluid 2011 ·SHILAP Revista de lepidopterología ·Magnus Vrethem, Mona Widhe, Jan Ernerudh, Ulf Garpmo, Pia Forsberg	4
12	Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab 2010 ·Journal of Clinical Virology ·Jakob Paues, Magnus Vrethem	20
13	Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population 2010 ·Disability and Rehabilitation ·(unknown), Martin Tondel, Bodil Persson, Magnus Vrethem	12
14	Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities – A descriptive study 2009 ·Disability and Rehabilitation ·Gunilla Liedberg, Magnus Vrethem	15
15	CTLA‐4 dimorphisms in gammopathy‐associated peripheral neuropathy 1999 ·European Journal of Neurology ·Thomas Masterman, Arturs Ligers, Olle Olerup, Magnus Vrethem, Jan Hillert	4
16	High level of anticardiolipin antibodies is an unusual finding in an unselected stroke population 1995 ·European Journal of Neurology ·Charlotte Dahle, Magnus Vrethem, (unknown), Jan Ernerudh	2
17	Avidity distribution of antibodies against peripheral nerve myelin in patients with polyneuropathy associated with IgM monoclonal gammopathy and in healthy controls 1995 ·Journal of the Neurological Sciences ·Magnus Vrethem, Christina Ekerfelt, Jan Ernerudh	4
18	Susceptibility to demyelinating polyneuropathy in plasma cell dyscrasia may be influenced by amino acid position 9 of the HLA-DRβ chain 1993 ·Journal of Neuroimmunology ·Magnus Vrethem, Jan Ernerudh, Mabel Cruz, Olle Olerup, Göran Solders, (unknown), Oluf Andersen, Jan Hillert	13
19	Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope 1993 ·Journal of Neurology ·Pam Fredman, Jan Lycke, Oluf Andersen, Magnus Vrethem, Jan Ernerudh, Lars Svennerholm	25
20	Prognosis in Patients with Transient Ischaemic Attacks and Minor Stroke Associated with a Normal Angiogram 1990 ·European Neurology ·Magnus Vrethem, Isabelle Johansson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact